Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Hsuan Li

Showing results (41-50 of 62) with videos related to

Pageof 7
Sort By:
Oncotarget|November 21, 2015
Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinomaMei-Chuan Chen, Hui-Hsuan Huang, Chin-Yu Lai, et al.
Journal of Clinical Medicine|May 14, 2025
The Triglyceride-Glucose Index as a Biomarker for Insulin Resistance Following Hepatitis C Virus Eradication: A Prospective Cohort StudyShih-Hsiung Shen, Hsin-Ju Tsai, Yu-Hsuan Li, et al.
Aging Cell|June 12, 2019
Aging-induced Akt activation involves in aging-related pathologies and Aβ-induced toxicityYu-Ru Chen, Yu-Hsuan Li, Tsung-Chi Hsieh, et al.
Journal of the Chinese Medical Association : JCMA|September 19, 2024
The impact of the COVID-19 pandemic on dyslipidemia in peritoneal dialysis patientsFan-Yu Chen, Shu-En Li, Jen-En Tsai, et al.
Organic & Biomolecular Chemistry|June 16, 2018
Correction: 2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibitionKunal Nepali, Sunil Kumar, Hsiang-Ling Huang, et al.
Organic & Biomolecular Chemistry|December 24, 2015
2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibitionKunal Nepali, Sunil Kumar, Hsiang-Ling Huang, et al.
Bioorganic Chemistry|March 28, 2021
Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavityCheng Peng, Yu-Hsuan Li, Chao-Wu Yu, et al.
Chembiochem : a European Journal of Chemical Biology|June 22, 2013
1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines histone deacetylase inhibitors are potent cytokine release suppressorsHsueh-Yun Lee, Chia-Ron Yang, Mei-Jung Lai, et al.
European Journal of Medicinal Chemistry|July 20, 2020
Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cellsWei-Cheng Wu, Yi-Min Liu, Yu-Hsuan Liao, et al.
Molecular Medicine Reports|April 25, 2025
CDK5 targets p21<sup>CIP1</sup> to regulate thyroid cancer cell proliferation and malignancy in patientsMin-Che Tung, Muhammet Oner, Shiuan-Woei Soong, et al.
Pageof 7

Showing results (41-50 of 62) with videos related to

Sort By:
Pageof 7
Oncotarget|November 21, 2015
Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinomaMei-Chuan Chen, Hui-Hsuan Huang, Chin-Yu Lai, et al.
Journal of Clinical Medicine|May 14, 2025
The Triglyceride-Glucose Index as a Biomarker for Insulin Resistance Following Hepatitis C Virus Eradication: A Prospective Cohort StudyShih-Hsiung Shen, Hsin-Ju Tsai, Yu-Hsuan Li, et al.
Aging Cell|June 12, 2019
Aging-induced Akt activation involves in aging-related pathologies and Aβ-induced toxicityYu-Ru Chen, Yu-Hsuan Li, Tsung-Chi Hsieh, et al.
Journal of the Chinese Medical Association : JCMA|September 19, 2024
The impact of the COVID-19 pandemic on dyslipidemia in peritoneal dialysis patientsFan-Yu Chen, Shu-En Li, Jen-En Tsai, et al.
Organic & Biomolecular Chemistry|June 16, 2018
Correction: 2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibitionKunal Nepali, Sunil Kumar, Hsiang-Ling Huang, et al.
Organic & Biomolecular Chemistry|December 24, 2015
2-Aroylquinoline-5,8-diones as potent anticancer agents displaying tubulin and heat shock protein 90 (HSP90) inhibitionKunal Nepali, Sunil Kumar, Hsiang-Ling Huang, et al.
Bioorganic Chemistry|March 28, 2021
Inhibitor development of MTH1 via high-throughput screening with fragment based library and MTH1 substrate binding cavityCheng Peng, Yu-Hsuan Li, Chao-Wu Yu, et al.
Chembiochem : a European Journal of Chemical Biology|June 22, 2013
1-arylsulfonyl-5-(N-hydroxyacrylamide)indolines histone deacetylase inhibitors are potent cytokine release suppressorsHsueh-Yun Lee, Chia-Ron Yang, Mei-Jung Lai, et al.
European Journal of Medicinal Chemistry|July 20, 2020
Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cellsWei-Cheng Wu, Yi-Min Liu, Yu-Hsuan Liao, et al.
Molecular Medicine Reports|April 25, 2025
CDK5 targets p21<sup>CIP1</sup> to regulate thyroid cancer cell proliferation and malignancy in patientsMin-Che Tung, Muhammet Oner, Shiuan-Woei Soong, et al.
Pageof 7